Title: Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study
Authors: Vergote, Ignace ×
Jimeno, Antonio
Joly, Florence
Katsaros, Dionyssios
Coens, Corneel
Despierre, Evelyn
Marth, Christian
Hall, Marcia
Steer, Christopher B
Colombo, Nicoletta
Lesoin, Anne
Casado, Antonio
Reinthaller, Alexander
Green, John
Buck, Martin
Ray-Coquard, Isabelle
Ferrero, Annamaria
Favier, Laure
Reed, Nick Simon
Curé, Hervé
Pujade-Lauraine, Eric #
Issue Date: 1-Feb-2014
Publisher: Grune & Stratton
Series Title: Journal of Clinical Oncology vol:32 issue:4 pages:320-6
Abstract: This trial evaluated the efficacy of maintenance erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, after first-line chemotherapy.
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science